A Multi-Center, Randomized, Double-Blind, Placebo-and Active Comparator-Controlled Phase 3 Study to Evaluate the Efficacy and Safety of BMS-986165 in Subjects with Moderate-to-Severe Plaque Psoriasis
Administered By
Awarded By
Contributors
- Murray, John Carroll Principal Investigator
Start/End
- January 3, 2019 - May 14, 2020